BRITAIN now has more households with someone on fat jabs living there than it has vegetarian homes, according to a poll.
At least one person is using a GLP-1 weight loss drug in an estimated 8.5 per cent of homes and that number is expected to exceed ten per cent by next year.


The medication’s popularity has continued to surge after the launch of tablet versions this summer.
The figure is equal to the number of households where someone is vegetarian — 5.5 per cent — or is a pescatarian, who eats fish and veg but not meat, which is three per cent.
Figures suggest more than 2.6million people currently take weight-loss injections or pills and a similar number have used them in the past.
The Vegetarian Society says just over three million people in the UK are veggie or vegan.
Hippie Neil from 1980s BBC sitcom The Young Ones is one of the most famous fictional veggies.
Sir Paul McCartney and Traitors winner Romesh Ranganathan have also shunned meat and fish.
Worldpanel by Numerator, which conducted the poll, said: “This is not a flash in the pan trend, but a seismic change. GLP-1 users are now as common as vegetarians and pescatarians combined.”
About one in nine users of the medicines take pills rather than jabs, the survey of 9,629 households found.
And it said widespread use of the appetite-crushing drugs has changed shopping habits, with patients spending less on crisps and booze and more on clothes and cosmetics.
Katharine Jenner, of the Obesity Health Alliance, said: “The growing use of GLP-1 medicines is already influencing what foods people buy and could have significant implications for the food industry.
“While these medicines will support some individuals, they do not change broader factors that influence diet and health. Access to affordable, nutritious food remains important for all.”
And the Vegetarian Society said: “The issue with GLP-1s is that once users reach a target weight and stop using them, appetite and cravings return.
“Adopting a well-balanced diet rich in plant-based foods can help people lose weight without needing to use GLP-1s in the first place.”